搜索到 1000 条关于 온라인바카라사이트▧rAY800˛TOP♩W88 download◁카지노쿠폰지급∋배트맨토토∇단폴⊇djsxorxmzkwlsh 的文章

2012.09.19 2011秋季华南地区最大的药品、保健品交易会

费用:】  T区(光地):800元/ m2(36m2起租)(凡特装展位须缴交特装施工管理费:28元/平方米)  A区(标准)展位:人民币...%  国际标准展位3m×3m=9m2(配置标准:楣板一条,一张洽谈桌,二把椅子,220V(限500W)电源插座一个,一个纸篓,两支光管,三面展板,每块展板
重度抑郁症患者生活质量不一定眼见为实

2015.04.10 重度抑郁症患者生活质量不一定眼见为实

美国加州大学精神病学和生物行为科学医学系的W. W. IsHak的一项研究显示,生活质量改善的MDD患者的生活质量实际上可能并未改善。
低血糖或增加心血管事件后死亡风险

2014.11.06 低血糖或增加心血管事件后死亡风险

低血糖是1型糖尿病最常见、最危重的急性并发症。如果得不到及时治疗,有可能会危及患者生命。但是,关于低血糖对糖尿病患者心血管事件后死亡率影响的证据较为有限。为此,来自澳大利亚墨尔本大学 Tom W.C. Lung教授及其团队进行了一项研究,旨在探讨既往严重低血糖病史是否与1型糖尿病患者主要心血管事件(心肌梗死[MI
当前及既往吸烟均可增加糖尿病风险

2014.10.29 当前及既往吸烟均可增加糖尿病风险

吸烟与多种不良健康行为有关,例如体重活动减少、大量饮酒、以及低水果蔬菜饮食等,而这些不良健康行为有可能会促进2型糖尿病发生。但是,虽然以往有研究表明,吸烟患者罹患2型糖尿病的风险增加,但这些研究往往未能完全校正各种潜在混杂因素。为此,来自荷兰国立公共卫生和环境研究所的Annemieke M. W
FBT为青少年神经性厌食症首选治疗方法

2014.10.13 FBT为青少年神经性厌食症首选治疗方法

神经性厌食症(AN)是一种高发病率和病死率的疾病。家庭治疗(FBT)是青少年AN的一种询证治疗,但是接受这种疗法的人中,获得康复的人还不到一半。因此,确定其他阻止AN慢性发展的询证治疗方法很有必要。为了比较FBT和系统性家庭治疗(SyFT)治疗青少年早发AN的治疗效果,美国斯坦福大学精神病学与行为科学系的W
阿立哌唑长效针剂优于口服药物

2014.07.22 阿立哌唑长效针剂优于口服药物

精神分裂症是一种反复发作的慢性迁延性疾病,每一次复发都有可能导致患者认知功能和社会功能下降,进而影响患者的预后。因此,有效预防精神分裂症的复发,维持并缓解症状的意义重大。因斯布鲁克医科大学,生物精神病学系,精神病学和心理治疗系,W. Wolfgang Fleischhacker博士等人的一项研究结果

2012.09.19 2010 第五届国际基因组学大会(ICG-V)

, please click: http://www.genomeconference.org/pages/Abstract.aspxTop Poster

2012.09.19 2012 中国医疗器械高峰论坛

trials and regulatory affairs
A special showcase of top 10 Chinese innovative device companies and top 5 selected US/EU device companies interested in China

2012.09.19 2011年生物仿制药会议(Biosimilars Asia 2011)

时间: 2011-5-23 至 2011-5-26
地点:Grand Hyatt Shanghai
主办单位: IBC Asia (S) Pte Ltd

会议简介

According to Business Insights, an estimated $25bn worth of biologics will lose patent protection by 2016, creating a significant market opportunity for biosimilars. However, the reality is that biosimilar development is a risk-fraught activity that demands significant resources in R&D, manufacturing expertise, regulatory know-how, clinical-trial capabilities, and a high level of financial investment.

Biosimilar development is riddled with complexities, ranging from regulatory, to manufacturing to marketing, and is one of the most expensive propositions in the pharmaceutical industry. It is estimated that it costs between US$100-200 million to bring a biosimilar product to market. With so much at stake, biosimilars represent not only substantial growth but equally risk..

IBC’s 2nd Annual Biosimilars Asia 2011 Summit is the ONLY conference in Asia catering to this region’s specific queries. With unprecedented insights from leading innovators and biosimilar companies, you will network and learn how to strategically position your company to maximize your ROI. Biosimilars Asia 2011 is attended by key stakeholders in the region and beyond, enabling you to make informed strategic decisions.

5 Reasons To Attend
  • Only conference in Asia which addresses concerns faced by the Asian biosimilar companies with experts from the region and beyond
  • Learn from and personally meet senior executives from the major stakeholders amongst from biosimilar to innovator companies
  • The most comprehensive event highlighting key challenges in the industry including manufacturing, marketing, pricing, transitioning from generics to biosimilars and regulatory issues
  • Showcasing unique case studies from leading Asian and international biosimilar companies
  • Gather the latest insights from regional biosimilar companies and MNCs about their strategic decisions and how they are positioning themselves for success

Industry Gurus / Speakers
Biocon, Pfizer, Genentech, Roche, Teva, Hospira, Sandoz, Momenta, Intas, Dr Reddy’s, Shenzhen Main Luck Pharmaceuticals

Past Attendees Include
Vice President, ASTRAZENECA INNOVATION CENTER (China)
Senior Director, GENENTECH INC, (USA)
Managing Director, BECTON DICKINSON CO (BD BIOSCIENCES) (Singapore)
Managing Director, ASAHI GLASS CO LTD (Japan)
Deputy General Manager, SINOPHARM (China)
Head, Biotech Research, USV LTD (India)
General Manager, JCR PHARMACEUTICALS CO LTD (Japan)
Vice President, R&D/Business Development, MAIN LUCK PHARMACEUTICALS INC (China)
Senior Research Associate, HANWHA CHEMICAL (South Korea)
Vice President, BOEHRINGER INGELHEIM GMBH (Germany)
General Manager, GLAXOSMITHKLINE (CHINA) INVESTMENT CO LTD (China)
IP Director, HOSPIRA (AUSTRALIA)
President, MYCENAX BIOTECH INC (Taiwan)
Senior Director, MERCK & CO INC (USA)
Associate Director, DR REDDY''''''''S LABORATORIES LTD (India)
Chairman, SHENZHEN SCIPROGEN BIO-PHARMACEUTICAL CO LTD (SCIPROGEN) (China)COO, SHANGHAI CELGEN BIOPHARMACEUTICALS (China)
Chief Representative, TTY BIOPHARM CO LTD (Taiwan)COO, 3SBIO (China)
Project Director, JIANGSU CHIA TAI TIANQING PHARMACEUTICAL CO LTD (China)Associate Director, PFIZER INVESTMENT CO LTD (China)
General Manager, NIPPON KAYAKU CO LTD (Japan)
President, HENLIUS BIOPHARMACEUTICALS INC & SHANGHAI HENLIUS BIOTECH (USA)
Vice President, RANBAXY (USA)

Registration

FEES per delegate
Early Bird Rate
Register & Pay before 11 March 2011
Special Rate
Register & Pay before 15 April 2011
Normal Rate
Register & Pay after 15 April 2011
Group Rate
Group of 3 or more
?
US$ / CNY
US$ / CNY
US$ / CNY
US$ / CNY
4 day package
(Conf + Pre & Post Workshops)
2,495 /
16,600
2,695 /
17,950
2,895 /
19,500
2,175 /
14,650
3.5 day package (Conf + Workshop C & A or B )

2,295 /
15,500

2,495 /
16,600
2,695 /
17,950
2,025 /
13,500
3 day package (Conf + Workshop A & B or C)
1,995 /
13,500
2,195 /
14,600
2,395 /
15,950

1,795 /
12,000

2.5 day package (Conf + Workshop A or B)
1,795 /
12,000
1,995 /
13,500
2,195 /
14,600
1,695 /
10,950
2 day package
(Conf only)
1,495 /
9,950
1,695 /
11,300
1,895 /
12,600
1,495 /
9,950

Register Now

PAYMENT TERMS

Payment must be received 10 business days prior to the event. To take advantage of discounts with an expiry cut-off date, registration and payment must be received by the cut off date.

Payments by Singapore Dollars (S$)

  • Payments by S$ bank draft or cheque should be made in favour of “IBC Asia (S) Pte Ltd” payable in Singapore.
  • Payment by telegraphic transfer in S$ must be made to:
    IBC Asia (S) Pte Ltd
    A/C No.: 147-059513-001 (SGD)
    The Hongkong and Shanghai Banking Corporation Limited
    21 Collyer Quay, HSBC Building, Singapore 049320
    Bank Swift Code: HSBCSGSG
    Bank Code: 7232
  • Payment by Credit Card (AMEX, VISA or MASTERCARD). Please provide your Card Number, Name of Cardholder, Expiry Date and your Signature and send it by fax to +65 6508 2407.
Payments by RMB (CNY)
  • Payment by telegraphic transfer in CNY must be made to:
    A/C Name:
    A/C No.: 720-031103-001
    Beneficiary Bank:
    Bank Address: No. 1000 Lujiazui Rind Road,
    Pudong, Shanghai 200120, P.R. China
    Bank Swift Code: HSBCCNSH
CANCELLATIONS SUBSTITUTION
Should you be unable to attend, a substitute delegate is welcome at no extra charge. Cancellations must be received in writing at least 10 business days before the start of the event, to receive a refund less 10% processing fee per registration. The company regrets that no refund will be made available for cancellation notifications received less than 10 business days before the event.IMPORTANT NOTE:
Please quote the name of the delegate, event title and invoice number on the advice when remitting payment. Bank charges are to be deducted from participating organisations own accounts. Please fax your payment details (copy of remittance advice, cheque or draft to +65 6508 2407.

Attendance will only be permitted upon receipt of full payment. Participants wishing to register at the door are responsible to ensure all details are as published. IBC Asia will not be responsible for any event re-scheduled or cancelled.


DATA PROTECTION
The personal information entered during your registration/order, or provided by you, will be held on a database and may be shared with companies in the Informa Group in the UK and internationally. Sometimes your details may be obtained from or shared with external companies for marketing purposes. If you do not wish your details to be used for this purpose, please contact Winnie Seah (Database) on winnie.seah@ibcasia.com.sg Tel: +65 6508 2468 or Fax: +65 6508 2408.
联系方式电话:+65 650 82401

2020.06.17 【直播 | 现场】计算机辅助设计—分子模拟与蛋白互作研讨班(8.20-22)

。【报名回执】访问此链接填写报名回执(https://www.wjx.top/jq/80710449.aspx)【咨询请联系】QQ 号:2814500767邮箱
一例复杂的股骨髁上髁间骨折合并同侧股骨干骨折

2012.04.23 一例复杂的股骨髁上髁间骨折合并同侧股骨干骨折

尚可。病人入院时有休克,经补液及输血800ml后病情平稳,另外合并有左手2-4掌骨骨折和左腕掌侧Barton骨折,Barton骨折和股骨髁上髁间骨折...活动是有益的,这样的骨折牢固的内固定难了,是否可以石膏外固定,待断端机化粘连后(4W)再渐进锻炼!还是想看到宋老师的结果!当然如果有远期的结果就更好

2006.10.14 已婚人士对自身生育力的认识“不切实际”

调查显示,30至39岁的人们中间,88%的男性和57%的女性都相信自己不存在不育这个问题。 “不幸的是,他们这种认识极度不切实际。&rdquo... an infertility problem.But the new National Fertility Study found 88 per cent of men and 57
口服抗凝药预防房颤患者卒中的10大要点

2015.04.01 口服抗凝药预防房颤患者卒中的10大要点

,来自荷兰Onze Lieve Vrouwe Gasthuis医院的Freek W A Verheugt等在Lancet上详细介绍了口服抗凝药用于房颤的卒中预防

2013.12.13 迟发性性腺功能减退症或与中老年男性死亡率增加有关

大学Frederick C. W. Wu教授及其团队进行了一项研究,该研究发现重度LOH与全因死亡率和心血管死亡率风险大幅增加有关,睾酮水平和性症状存在与否都与
献给初学者:如何使用 NCBI 查找基因序列、mRNA、Promoter

2016.12.09 献给初学者:如何使用 NCBI 查找基因序列、mRNA、Promoter

。5. 点击上图出现的 Download/View Sequence/Evidence ,即下载查看序列等功能,结果如下图所示。在 Sequence

2015.09.25 北京妇产医院第五期女性盆腔器官脱垂手把手学习班

://www.bjogh.com.cn/dt/gg/download/1443145899828.p
上一页 1 2 3 ... 41 42 43 ... 48 49 50 下一页 到第